LMU chemist Professor Thomas Bein studies porous nanoparticles, which show great potential as vehicles for the delivery of drugs to specific target cells. Bein hopes that his research will lead to cancer treatments that have minimal side-effects.
Ludwig-Maximilians-Universität München
Interactome Media
None
R comics
Hillary Nez
Oxford University
ICGEB
Dr. Robert Nagourney
Michael Fernando and Josh Hurwitz
The Lancet Oncology
The Lancet Oncology
LLSC
Sparrow
CancerCare
American Cancer Society
Talking About Tumors
Dr. Faraz Badar
UCTV
Ochsner Cancer Institute
Breast Cancer Network Australia
Rebecca Rollan
Pablo Izquierdo
None
Dr. Anees Chagpar
Dr Geoffey McCowage, Senior Paediatric Oncologist, Sydney, Australia
Sanford Health News
Oxford University
University of Hawaiʻi Cancer Center
Macmillan Cancer Support
Rick
Cancer Treatment Centers of America (CTCA)
Marlene Ellis
RadioMD
ANZGOG
CancerCare
UCTV
School of Biomedical Engineering & Imaging Sciences, King's College London
Bazakah Radio
Breast Cancer Trials
Dr. Robert Nagourney
Cancer Informant
Johns Hopkins Medicine
Dr.MuraliSubramanian
Johns Hopkins Medicine
Christina Henry
CancerCare
Dana-Farber Cancer Institute
xCures
ICGEB
Archive
UCTV
UCTV
CancerCare
www.chroniclove.org
Kroll Care
None
CancerCare
HCG Oncology
CancerCare
Research To Practice
CancerCare
Martha gonzales
Riverside Cancer Institute
Cancer Assistance Program
Dana-Farber Cancer Institute
CancerCare
CancerCare
cancerGRACE
Deepu & Elsa
CancerCare
CancerCare
CancerCare
BCRF
CancerCare
CancerCare
drmuralisubramanian
CancerCare
CancerCare
Michael Karlfeldt
Cancer Treatment Centers of America
CancerCare
Oncology India
CancerCare
CancerCare
livontaglobal1
Craig Faulkner
CancerCare
None
CancerCare
GenScript Biotech Corp
Dr. Rosalyn Morrell
CancerCare
Cancer Network
VoiceAmerica
Dave Pratt
Adyson Tibbitts
Alyssa Fischer-Reeder
Cancer Survivor Guide
Factory Originals & 6Foot6 Productions
Belinda Wagner